Evidence map›Paper›PMID 40739387›Full record

ArticleCommunications chemistry2025

Titanocenes functionalization with high chemical diversity via titanium protecting groups.

Emanuele Casali, Andrea Gandini, Gabriele Merlo, Lorenzo Carli, Jan J Weigand, Alessio Porta, Giuseppe Zanoni

Abstract read
In one paragraph

Article in Communications chemistry, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emanuele CasaliDepartment of Chemistry, University of Pavia, Viale Taramelli 12, 27100, Pavia, Italy. emanuele.casali@unipv.it.ORCID http://orcid.org/0000-0001-7501-5213
Andrea GandiniDepartment of Chemistry, University of Pavia, Viale Taramelli 12, 27100, Pavia, Italy.
Gabriele MerloDepartment of Chemistry, University of Pavia, Viale Taramelli 12, 27100, Pavia, Italy.
Lorenzo CarliDepartment of Chemistry, University of Pavia, Viale Taramelli 12, 27100, Pavia, Italy.
Jan J WeigandFaculty of Chemistry and Food Chemistry, Technische Universitaet Dresden, 01062, Dresden, Germany.ORCID http://orcid.org/0000-0001-7323-7816
Alessio PortaDepartment of Chemistry, University of Pavia, Viale Taramelli 12, 27100, Pavia, Italy. alessio.porta@unipv.it.ORCID http://orcid.org/0000-0002-2564-9696
Giuseppe ZanoniDepartment of Chemistry, University of Pavia, Viale Taramelli 12, 27100, Pavia, Italy. gz@unipv.it.ORCID http://orcid.org/0000-0003-1530-9409

Funding

Regione Lombardia (Region of Lombardy) E46D17000110009
6 · The paper itself

Abstract

Titanocenes are well-recognized for their diverse applications in catalysis and biomedical research. Despite their potential, challenges related to stability and functionalization have limited broader utility, especially in medicinal chemistry. In this study, we present a strategy for the functionalization of titanocenes using a class of titanium protecting groups. This approach provides enhanced control over reactivity and significantly broadens the scope of structurally diverse modifications accessible for these complexes. Furthermore, we demonstrate the successful integration of a BODIPY fluorophore into titanocene-based systems, enabling advanced cellular imaging and visualizing the real perinuclear distribution of these organometallic compounds in living cell. The efficient incorporation of biomolecules such as biotin and cholesteryl derivatives through click-chemistry ligation underscores the potential of this method to facilitate the development of titanocene-based agents for pharmaceutical applications. By addressing previous limitations, this work paves the way for more effective utilization of titanocenes in both synthetic and biomedical fields.

Identifiers

PMID40739387
PMCPMC12310976

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.